Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in Chemotherapy-Naive Advanced NSCLC
NCT00550537Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Oct 2007
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Vanderbilt-Ingram Cancer Center. Started Oct 2007; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00550537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550537.